← Eichor
Condition: Agitation Psychomotor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Agitation Psychomotor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Melatonin for Post Tonsillectomy Emergence Agitation in Pediatric
NA · 1 location(s) · Benha University · NCT07375342Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Phase 2 · 8 location(s) · Teikoku Pharma USA, Inc. · NCT06052254Acute Agitation in Emergency Psychiatry
Phase 2/Phase 3 · 1 location(s) · Lone Baandrup · NCT06752616Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.
Phase N/A · 1 location(s) · University Hospital, Clermont-Ferrand · NCT05522647Neurosteer Bedside Monitoring System
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06718764Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
Phase 2 · 1 location(s) · Eastern Virginia Medical School · NCT04436081Nabilone for Agitation Blinded Intervention Trial
Phase 3 · 6 location(s) · Sunnybrook Health Sciences Centre · NCT04516057Protocolized Receptive Music Intervention to Reduce Care Refusal in Nursing Home Residents With Major Neurocognitive Dis
NA · 12 location(s) · LNA SANTE · NCT07730957Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)
NA · 5 location(s) · Brent Forester · NCT03926520Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Phase 3 · 44 location(s) · Suven Life Sciences Limited · NCT05397639Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients
NA · 1 location(s) · Milton S. Hershey Medical Center · NCT07649876Therapeutic Cuddling in Critically Ill Children
NA · 1 location(s) · University of Calgary · NCT07562048the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave
Phase N/A · 2 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06543602A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Phase 3 · 258 location(s) · Bristol-Myers Squibb · NCT06937229Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
Phase 2 · 1 location(s) · Bernard (Barry) Baumel · NCT06781333Goal-Directed Sedation in Mechanically Ventilated Infants and Children
Phase 3 · 1 location(s) · Vanderbilt University Medical Center · NCT04801589Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants W
Phase 2 · 53 location(s) · Celgene · NCT06808984A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use
NA · 5 location(s) · Radboud University Medical Center · NCT05783505Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit
NA · 1 location(s) · HOSPITAL BRITANICO DE BUENOS AIRES · NCT07369258Evaluation of The Relationship Between Perioperative Hypothermia and Emergence Agitation
Phase N/A · 1 location(s) · Kocaeli City Hospital · NCT06543134Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care
Phase 1/Phase 2 · 3 location(s) · Bruyère Health Research Institute. · NCT04824144Clinical Trial on Agitation in Alzheimer's Dementia
Phase 2 · 31 location(s) · IGC Pharma, LLC · NCT05543681PARO-agitation-study
NA · 1 location(s) · Hannover Medical School · NCT07568093
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.